Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | February 14, 2025 05:05pm

Gainers

  • Moleculin Biotech (NASDAQ:MBRX) stock increased by 58.3% to $2.01 during Friday's pre-market session. The market value of their outstanding shares is at $6.7 million.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) stock moved upwards by 55.34% to $0.45. The market value of their outstanding shares is at $8.2 million.
  • CNS Pharma (NASDAQ:CNSP) stock increased by 43.69% to $0.15. The company's market cap stands at $8.9 million.
  • OS Therapies (AMEX:OSTX) shares increased by 40.2% to $2.79. The market value of their outstanding shares is at $59.2 million.
  • AVITA Medical (NASDAQ:RCEL) stock moved upwards by 13.78% to $9.99. The market value of their outstanding shares is at $261.9 million. As per the news, the Q4 earnings report came out yesterday.
  • Creative Medical Tech (NASDAQ:CELZ) shares increased by 12.85% to $5.18. The company's market cap stands at $9.0 million.

Losers

  • Firefly Neuroscience (NASDAQ:AIFF) shares fell 17.3% to $12.78 during Friday's pre-market session. The market value of their outstanding shares is at $102.2 million.
  • Design Therapeutics (NASDAQ:DSGN) stock fell 16.63% to $3.31. The market value of their outstanding shares is at $187.4 million.
  • ProPhase Labs (NASDAQ:PRPH) shares decreased by 16.18% to $0.28. The company's market cap stands at $8.6 million.
  • Tivic Health Systems (NASDAQ:TIVC) shares declined by 16.09% to $0.63. The company's market cap stands at $5.2 million.
  • NKGen Biotech (NASDAQ:NKGN) shares decreased by 15.73% to $0.65. The market value of their outstanding shares is at $22.9 million.
  • NeuroPace (NASDAQ:NPCE) shares declined by 15.47% to $10.22. The market value of their outstanding shares is at $305.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AIFF CELZ CNSP DSGN MBRX NKGN NPCE OSTX PRPH RCEL TIVC VRPX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist